These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10867451)

  • 21. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
    Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
    Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical markers in colorectal cancer: diagnostic and therapeutic implications.
    Luk GD; Desai TK; Conteas CN; Moshier JA; Silverman AL
    Gastroenterol Clin North Am; 1988 Dec; 17(4):931-40. PubMed ID: 3068151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3.
    Di Gioia D; Blankenburg I; Nagel D; Heinemann V; Stieber P
    Clin Chim Acta; 2016 Oct; 461():1-7. PubMed ID: 27451906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
    Iarŭmov N; Ignatov A; Viiachki I
    Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of serum tumor markers.
    Bates SE
    Ann Intern Med; 1991 Oct; 115(8):623-38. PubMed ID: 1716430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas.
    Guadagni F; Roselli M; Amato T; Abbolito MR; Cosimelli M; Mannella E; Greiner JW; Schlom J
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):293-6. PubMed ID: 2092139
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical utility of determining tumor markers in patients with signs and symptoms of cancer.
    Trapé J; Sala M; Franquesa F; Ordeig JM; Soler-Bel JM; Bustamante E; Pérez R; Aligué J; Montesinos J; Arnau A; Ordeig-Villanueva R
    Clin Chem Lab Med; 2015 Feb; 53(3):485-91. PubMed ID: 25274947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
    Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
    Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of predictive markers for patients with advanced colorectal cancer.
    Byström P; Berglund Å; Nygren P; Wernroth L; Johansson B; Larsson A; Glimelius B
    Acta Oncol; 2012 Sep; 51(7):849-59. PubMed ID: 22974092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and biochemical markers in colorectal cancer.
    McDermott U; Longley DB; Johnston PG
    Ann Oncol; 2002; 13 Suppl 4():235-45. PubMed ID: 12401696
    [No Abstract]   [Full Text] [Related]  

  • 37. Ornithine decarboxylase as a marker for colorectal polyps and cancer.
    Luk GD; Moshier JA; Ehrinpreis MN
    Prog Clin Biol Res; 1988; 279():227-39. PubMed ID: 3054922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tumor markers in liver metastases of colorectal carcinoma].
    Moreno Sierra J; Vincent E; Gea M; Ortega MD; Borque M; Madrigal J; Pimentel C; Represa J
    Rev Esp Enferm Dig; 1990 Sep; 78(3):139-44. PubMed ID: 1980590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor markers in colorectal cancer.
    de Thibault de Boesinghe L
    J Belge Radiol; 1989 Oct; 72(5):415-7. PubMed ID: 2600057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Galectin-1 and 90K/Mac-2BP Correlated with the Tumor Stages of Patients with Colorectal Cancer.
    Wu KL; Chen HH; Pen CT; Yeh WL; Huang EY; Hsiao CC; Yang KD
    Biomed Res Int; 2015; 2015():306964. PubMed ID: 26448934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.